DongKook Pharmaceutical Co., Ltd. (KOSDAQ: 086450)

DongKook Pharmaceutical Revenue

DongKook Pharmaceutical had revenue of 200.88B KRW in the quarter ending September 30, 2024, with 13.85% growth. This brings the company's revenue in the last twelve months to 789.11B, up 11.21% year-over-year. In the year 2023, DongKook Pharmaceutical had annual revenue of 730.99B with 10.48% growth.

• Revenue (ttm): 789.11B
• Revenue Growth: +11.21%
• P/S Ratio: 0.90
• Revenue / Employee: 697.71M
• Employees: 1,131
• Market Cap: 709.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%
Dec 31, 2020	559.10B	76.82B	15.93%
Dec 31, 2019	482.28B	81.47B	20.33%